Latest News

Date Title Topic
19 May 2016 FDA Approves Atezolizumab for Treatment of Urothelial Carcinoma Genitourinary cancers - Cancer Immunology and Immunotherapy
18 May 2016 Three Generations of Cancer Immunotherapies Cancer Immunology and Immunotherapy
13 May 2016 Can Regulators Influence the Affordability of Medicines? Bioethics, legal and economic issues
12 May 2016 Anti-Proliferative Effect and Predictive Biomarkers to Palbociclib in Early Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
12 May 2016 May 2016 – Image of the Month
11 May 2016 Microwave Ablation for Treating Liver Metastases Gastrointestinal cancers
11 May 2016 The Lugano Classification Recommendations for Hodgkin’s and Non-Hodgkin’s Lymphoma
10 May 2016 Residual Disease in Oncogene-Driven Solid Tumours Anticancer agents & Biologic therapy
09 May 2016 Imatinib in the context of the anticancer immunosurveillance system Anticancer agents & Biologic therapy
06 May 2016 EMA Recommends Granting a Marketing Authorisation for Lutetium (177 Lu) Chloride Imaging - Endocrine and neuroendocrine tumours
Ovarian Cancer
04 May 2016 EMA Recommends Extending the Authorised Indications for Obinutuzumab Haematologic malignancies - Anticancer agents & Biologic therapy
03 May 2016 EMA Adopts a New Indication for Everolimus Endocrine and neuroendocrine tumours - Anticancer agents & Biologic therapy
02 May 2016 EMA Adopts a New Indication for Bevacizumab Lung and other thoracic tumours - Anticancer agents & Biologic therapy
28 Apr 2016 Register today for ESMO 2016